Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck
European Journal of Cancer2004Vol. 40(18), pp. 2748–2752
Citations Over Time
Florence Duffaud, Markus Borner, P. Chollet, J. B. Vermorken, Joël S. Bloch, M. Degardin, F. Rolland, Christian Dittrich, B. Barón, Didier Lacombe, P. Fumoleau
Related Papers
- → Determinants of variability in waiting times for radiotherapy in the treatment of breast cancer(2010)19 cited
- → Investigation on baseline toxicity to rats based on aliphatic compounds and comparison with toxicity to fish: Effect of exposure routes on toxicity(2014)10 cited
- → Preclinical Toxicity Studies(2022)2 cited
- → ON THE DETERMINATION OF THE TOXICITY OF NEOARSPHENAMINE I. THE INCREASE IN TOXICITY ON EXPOSURE TO AIR(1933)1 cited
- STUDY ON THE EFFECTS OF RADIOTHERAPY ON T-CELL SUBGROUPS OF THE MALIGNANT TUMOR PATIENTS(2000)